Magnesium the new frontier

Magnesium deficiency manifests clinically with nonspecific symptoms in mild-to-moderate cases and severe neuromuscular, cardiovascular, and metabolic abnormalities when serum magnesium falls below 1.2 mg/dL (0.5 mmol/L).

Patients with hypomagnesemia commonly present with lethargy, muscle cramps, and muscle weakness.

These nonspecific symptoms often lead to the diagnosis being overlooked, particularly because serum magnesium is not routinely measured in most clinical settings.

 The clinical presentation is frequently complicated by concurrent electrolyte derangements, including hypocalcemia, hypokalemia, and metabolic alkalosis.

In severe hypomagnesemia, low serum magnesium

- Neuromuscular irritability: carpopedal spasm, seizures, and tremors  

- Cardiovascular abnormalities: arrhythmias and vasoconstriction    

- Metabolic disorders: insulin resistance and chondrocalcinosis  

Low Magnesium concentration, effects hypokalemia, with refractory hypokalemia dependent on magnesium correction .

Low serum magnesium levels are associated with increased hospitalization rates and mortality, especially when concurrent hypokalemia is present.

Laboratory assessment relies primarily on serum magnesium measurement, which correlates with symptom development but is a poor proxy for total body stores, as less than 1% of total body magnesium resides in plasma.

Less than 1% of total body magnesium is in plasma, making serum magnesium an unreliable marker of tissue stores.

Intracellular magnesium can be depleted even when serum levels remain normal, suggesting that reliance on blood levels alone likely underestimates the true prevalence of hypomagnesemia.

Hypomagnesemia is estimated to affect 2.5% to 15% of the general population, with higher rates observed in hospitalized patients, individuals with chronic diseases, and those on certain medications.

In patients with chronic alcohol-use disorder, the prevalence approaches 30%, driven by inadequate dietary intake, gastrointestinal malabsorption, and reversible ethanol-induced renal tubular dysfunction.

Drug-induced hypomagnesemia, particularly related to proton pump inhibitor therapy, is a common and often overlooked cause. 

Most patients with mild-to-moderate magnesium deficiency are asymptomatic, and when symptoms do occur, they are often nonspecific and easily attributed to other conditions.

In elderly populations, asthenia, sleep disorders, hyperemotionality, and cognitive disturbances are frequently confused with age-related changes, delaying diagnosis.

Symptomatic hypomagnesemia is typically associated with multiple concurrent electrolyte abnormalities, including hypokalaemia, hypocalcaemia, and metabolic acidosis, which complicate the clinical picture.

When magnesium deficiency becomes severe, neuromuscular irritability is the predominant clinical feature, manifesting as weakness, tremors, muscle cramps, spasms, and a positive Trousseau's sign.

Seizures can occur in the most severe cases.

Cardiovascular manifestations include irregular heartbeat and arrhythmias, with cardiac arrest representing a life-threatening complication of extreme hypermagnesemia rather than hypomagnesemia.

In chronic hypomagnesemia, associations with hypertension, type 2 diabetes mellitus, metabolic syndrome, and increased cardiovascular risk have been documented, though causality remains under investigation. 

Renal manifestations of genetic hypomagnesemia syndromes include nephrocalcinosis and impaired renal function, particularly in hypercalciuric hypomagnesemias caused by mutations in CLDN16 and CLDN19.

Magnesium depletion also suppresses parathyroid hormone release and induces peripheral resistance to its action, explaining the persistence of hypocalcemia until magnesium stores are replenished.

Hypocalcemia typically corrects within minutes to hours after restoration of normal plasma magnesium concentrations.

In pregnant women, magnesium deficiency can be a sign of preeclampsia, warranting measurement of serum magnesium in this population.

Chronic mild-to-moderate hypomagnesemia has also been implicated in the pathogenesis of osteoporosis, migraines, depression, stress-related conditions, Alzheimer's disease, chronic fatigue, fibromyalgia, and certain cancers, though the evidence for these associations varies in strength. 

In hospitalized patients with chronic alcohol-use disorder, plasma magnesium concentrations may decrease from normal or slightly reduced values to severely reduced levels over several days, unmasking total-body depletion.

The intracellular shift of magnesium following correction of acidosis, administration of glucose-containing fluids, increased catecholamines, and respiratory alkalosis during alcohol withdrawal further complicates assessment.

Treatment depends on the severity of symptoms and the presence of life-threatening complications.

Patients with symptomatic hypomagnesemia should be treated with intravenous magnesium, while oral replacement is reserved for asymptomatic patients.

Oral replacement is effective at slowly replenishing body stores, intravenous replacement reserved for severe or life-threatening cases.

Refractory hypokalaemia and hypocalcaemia will not respond to treatment until magnesium deficiency is corrected.